Presentation

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

REGISTER for free or LOG IN to view this content

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Heart Failure

Heart Failure Pharma

Presentation

ESC 2019

PARAGON-HF

HFpEF

Up Next

Presentation

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

More slides +

Presentation

One-year Outcomes After ST Elevation Myocardial Infarction

Presenter: Uwe Zeymer

September 01, 2019

Presentation

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.